Wegovy vs Mounjaro: Which Medication Leads to More Weight Loss?

Key Point 1Mounjaro (tirzepatide) has demonstrated greater weight loss compared to Wegovy (semaglutide) in clinical trials.

Key Point 2Both medications work by mimicking hormones that regulate appetite and blood sugar, but Mounjaro targets two hormones (GIP and GLP-1) while Wegovy targets only one (GLP-1).

Key Point 3Common side effects for both drugs include nausea, diarrhea, and vomiting, but side effect profiles can vary among individuals.

Key Point 4Hi Doctor AI offers a convenient way to get a consultation with an EU-licensed doctor to see if weight loss medication is right for you.

Understanding Wegovy and Mounjaro

Wegovy (semaglutide) and Mounjaro (tirzepatide) are prescription medications used for chronic weight management in adults with obesity or overweight, who also have weight-related medical problems. These medications belong to a class of drugs known as incretin mimetics, which mimic the effects of natural hormones in the body to regulate appetite and blood sugar levels.

Hi Doctor AI provides telemedicine consultations. All treatments are prescribed by EU-licensed doctors after reviewing your medical history. We do not sell or ship medications—prescriptions can be used at any licensed pharmacy in the EU.

How Wegovy Works

Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist. GLP-1 is a hormone that is released in the gut after eating. It works by:

• Increasing insulin release from the pancreas when blood sugar is high.
• Decreasing glucagon secretion, which reduces glucose production in the liver.
• Slowing down gastric emptying, which helps you feel fuller for longer.
• Acting on areas of the brain that regulate appetite, reducing hunger and cravings.

Wegovy is administered as a weekly subcutaneous injection. The dosage is gradually increased over several weeks to minimize side effects.

How Mounjaro Works

Mounjaro is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. GIP and GLP-1 are both incretin hormones that play a role in regulating blood sugar and appetite. Mounjaro works by:

• Activating both GIP and GLP-1 receptors, enhancing insulin secretion and reducing glucagon secretion.
• Slowing gastric emptying, similar to Wegovy.
• Potentially having a greater impact on appetite regulation due to the dual action on GIP and GLP-1 receptors.

Mounjaro is also administered as a weekly subcutaneous injection, with dosages adjusted over time.

Clinical Trial Results: Comparing Weight Loss

Several clinical trials have compared the effectiveness of Wegovy and Mounjaro for weight loss. These trials have generally shown that Mounjaro leads to greater weight loss than Wegovy.

Mounjaro's Superior Weight Loss

Studies have indicated that individuals taking Mounjaro experienced a more significant reduction in body weight compared to those on Wegovy. In some trials, the average weight loss with Mounjaro was approximately 20-25% of initial body weight, while Wegovy resulted in an average weight loss of around 15-17%.

The difference in weight loss may be attributed to Mounjaro's dual action on both GIP and GLP-1 receptors, which could lead to a more pronounced effect on appetite and metabolism.

Considerations and Caveats

It's important to note that individual results can vary. Factors such as lifestyle, diet, exercise, and genetics can influence the amount of weight loss achieved with either medication. Additionally, clinical trials have specific inclusion and exclusion criteria, so the results may not be generalizable to everyone.

Side Effects and Safety Profiles

Both Wegovy and Mounjaro have similar side effect profiles, as they both affect the gastrointestinal system. Common side effects include:

• Nausea
• Diarrhea
• Vomiting
• Constipation
• Abdominal pain

These side effects are usually mild to moderate and tend to improve over time as the body adjusts to the medication. However, some individuals may experience more severe side effects that require medical attention.

Serious Side Effects

Rare but serious side effects can occur with both Wegovy and Mounjaro. These may include:

• Pancreatitis (inflammation of the pancreas)
• Gallbladder problems
• Kidney problems
• Allergic reactions

It's crucial to discuss your medical history and any existing health conditions with your doctor before starting either medication.

How Hi Doctor AI Helps

Hi Doctor AI offers a convenient and accessible way to explore weight management options. Skip the waiting room and get a consultation from the comfort of your home. Here's how it works:

1. Online Consultation: Fill out a short medical questionnaire and pay the 45€ consultation fee. No video call is needed.
2. Doctor Prescription: An EU-licensed doctor reviews your case and, if suitable, issues a valid prescription.
3. Get Your Prescription: Receive your prescription via email or WhatsApp. Use it at any pharmacy in the EU.

If a prescription isn't issued, you'll receive a full refund. Hi Doctor AI makes the process of getting started with weight management simple and stress-free.

Ready to Get Started?

Choosing between Wegovy and Mounjaro involves considering their effectiveness, potential side effects, and individual health factors. Mounjaro has demonstrated greater weight loss in clinical trials, but both medications can be valuable tools in a comprehensive weight management plan. Talk to a healthcare provider to determine the best option for your needs.

Ready to start your weight loss journey? Get your online consultation with Hi Doctor AI—EU-licensed doctors, 45€ consultation fee.